1) 大熊利忠:NSTと診療報酬. 小児外科, 39:752-756, 2007
2) 「臨床栄養と我が人生」(大熊利忠/著), 熊日出版, 2017
3) Vassilyadi F, et al:Hallmarks in the history of enteral and parenteral nutrition:from antiquity to the 20th century. Nutr Clin Pract, 28:209-217, 2013
4) Randall HT:Sixth annual Jonathan E. Rhoads lecture. Enteral nutrition:tube feeding in acute and chronic illness. JPEN, 8:113-136, 1984
5) Rhoads JE:The absorption of protein split products from chronic isolated colon loops. Am J Physiol, 125:707-712, 1939
6) Skiadas PK & Lascaratos JG:Dietetics in ancient Greek philosophy:Plato's concepts of healthy diet. Eur J Clin Nutr, 55:532-537, 2001
7) Liyanage T, et al:Effects of the Mediterranean Diet on Cardiovascular Outcomes-A Systematic Review and Meta-Analysis. PLoS One. 2016 Aug 10;11(8):e0159252. doi:10.1371/journal.pone.0159252.eCollection 2016
8) 「実験医学序説」(クロード・ベルナール/著, 三浦岱栄/訳), 岩波書店, 2015
9) Ryan JA Jr & Page CP:Intrajejunal feeding:development and current status. JPEN, 8:187-198, 1984
10) Omori Y:Recent progress in safety evaluation studies on plasticizers and plastics and their controlled use in Japan. Environ Health Perspect, 17:203-209, 1976
11) Braun JM, et al:Phthalate exposure and children's health. Curr Opin Pediatr, 25:247-254, 2013
12) Rose RJ, et al:The effect of temperature on di(2-ethylhexyl)phthalate leaching from PVC infusion sets exposed to lipid emulsions. Anaesthesia, 67:514-520, 2012
13) Gauderer MW, et al:Gastrostomy without laparotomy:a percutaneous endoscopic technique. J Pediatr Surg, 15:872-875, 1980
14) Yang Z, et al:Meta-analysis of the need for nasogastric or nasojejunal decompression after gastrectomy for gastric cancer. Br J Surg, 95:809-816, 2008.
15) Wilmore DW & Kehlet H:Management of patients in fast track surgery. BMJ, 333:473-476, 2001
16) Rose WC:Feeding experiments with mixtures of highly purified amino acids:I. The inadequacy of diets containing nineteen amino acids. J Biol Chem, 94:155-165, 1931
17) MacCoy RH, et al:Feeding experiments with mixtures of highly purified amino acids:VIII. Isolation and identification of a new essential amino acid. J Biol Chem, 112:283-302, 1935
18) Rose WC:The sequence of events leading to the establishment of the amino acid needs of man. American Journal of Public Health, 58:2020-2027, 1968
19) Greenstein JP, et al:Quantitative nutritional studies with water-soluble, chemically defined diets. I. Growth, reproduction and lactation in rats. Arch Biochem Biophys, 72:396-416, 1957
20) 千畑一郎, 他:Chemically Defined Dietについて. 栄養と食糧, 27:363-374, 1974
21) Sugimura T, et al:Quantitative nutritional studies with water-soluble, chemically defined diets. VII. Nitrogen balance in normal and tumor-bearing rats following forced feeding. Arch Biochem Biophys, 81:439-447, 1959
22) Sugimura T, et al:Quantitative nutritional studies with water-soluble, chemically defined diets. VIII. The forced feeding of diets each lacking in one essential amino acid. Arch Biochem Biophys, 81:448-455, 1959
23) Sugimura T, et al:Quantitative nutritional studies with water-soluble, chemically defined diets. IX. Further studies on d-glucosamine containing diets. Arch Biochem Biophys, 83:521-527, 1959
24) 味の素ホームページ「味の素グループの100年」 https://www.ajinomoto.com/jp/aboutus/history/story/
25) 小原正美, 他:アミノ酸の製造について. 有機合成化学協会誌, 20:676-687, 1962
26) 大熊利忠, 他:われわれの処方した成分栄養の臨床経験. 臨床外科, 34:547-553, 1979
27) 大熊利忠, 他:成分栄養法による食道癌術前術後の栄養管理. 日本消化器外科学会誌, 13:159-164, 1980
28) 岡田正, 他:高カロリー輸液中にみられた亜鉛欠乏症. 医学のあゆみ, 92:436-442, 1975
29) 井上吉弘, 他:特発性食道破裂の二治験例. 臨床と研究, 56:853-856, 1979
30) 小越章平:成分栄養法に関する研究. 日本消化器外科学会誌, 18:851-858, 1985
31) 岡村健二, 他:空腸栄養ろう専用チューブの開発と使用経験. 外科と代謝栄養, 25:418-426, 1991
32) 大熊利忠, 他:慢性炎症性腸疾患および食道癌術前術後症例に対する成分栄養ED-ACの臨床経験. 薬理と治療, 7:3051-3070, 1979
33) 大熊利忠, 他:EDによる慢性炎症性腸疾患及び消化管ろう孔の治療. JJPEN, 13:255-259, 1979
34) 松尾勇, 他:クローン病合併妊娠の1月例. 日本産婦人科学会雑誌, 38:616-619, 1986
35) 岡村健二, 他:成分栄養による乳び胸の栄養管理. 術後代謝研究会誌, 14:297-301, 1980
36) 成田久季, 他:成分栄養法によるcolon preparation. JJPEN, 2:421-425, 1980
37) Barbul A:Arginine:biochemistry, physiology, and therapeutic implications. JPEN, 10:227-238, 1986
38) Chow O & Barbul A:Immunonutrition:Role in Wound Healing and Tissue Regeneration. Adv Wound Care(New Rochelle), 3:46-53, 2014
39) Heyland DK & Novak F:Immunonutrition in the critically ill patient:more harm than good? JPEN, 25:S51-55, 2001
40) Matas R:The continued intravenous "drip":with remarks on the value of continued gastric drainage and irrigation by nasal intubation with a gastroduodenal tube (jutte) in surgical practice. Ann Surg, 79:643-661, 1924
41) Abdel-Halim RE:Contributions of Ibn Zuhr(Avenzoar)to the progress of surgery:a study and translations from his book AlTaisir. Saudi Med J, 26:1333-1339, 2005
42) 「心臓の動きと血液の流れ」(ウィリアム・ハーヴィ/著, 岩間吉也/訳), 講談社, 2005
43) 小越章平:静脈栄養の歴史. 日本臨床, 59(増刊号5):3-6, 2001
44) [Chirurgia infusoria](Major JD), 1667
45) Betcher AM:The Wood-Library Museum of Anesthesiology:Historical development of the Library-Museum. Anesthesiology, 22:618-632, 1961
46) Wood Library-Museum of Anesthesiologyホームページ「PAUL WOOD, MD. 1894-1963」https://woodlibrarymuseum.org/wood/
47) Latta T:Saline venous injection in cases of malignant cholera, performed while in the vapour-bath. Lancet, 19:208-209, 1832
48) Janakan G. & Ellis H:Dr Thomas Aitchison Latta(c1796-1833):pioneer of intravenous fluid replacement in the treatment of cholera. J Med Biogr, 21:70-74, 2013.
49) Schuberth O, & Wretlind A:[Experiences with intravenous fat emulsions]. Langenbecks Arch Klin Chir Ver Dtsch Z Chir. 287:486-489, 1957
50) Hallberg D, et al:Fat emulsions for complete intravenous nutrition. Postgrad Med, 43:307-316, 1967
51) [Exercitatio anatomica de motu cordis et sanguinis in animalibus](Harvey W, et al/author), Guilielmi Fitzeri, 1628
52) Wilmore DW:From Cuthbertson to fast-track surgery:70 years of progress in reducing stress in surgical patients. Ann Surg, 236:643-648, 2002
53) Cuthbertson DP:The influence of prolonged muscular rest on metabolism. Biochem J, 23:1328-1345, 1929
54) Cuthbertson DP:The disturbance of metabolism produced by bony and non-bony injury, with notes on certain abnormal conditions of bone. Biochem, 24:1244-1263, 1930
55) Cuthbertson DP:Observations on the disturbance of metabolism produced by injury to the limbs. Quart J Med. 25:233-246, 1932
56) Stahel PF, et al:"Metabolic staging" after major trauma-a guide for clinical decision making? Scand J Trauma Resusc Emerg Med, 18:34-36, 2010
57) Cuthbertson DP:Post-shock metabolic response. Lancet, 239:433-437, 1942
58) Cuthbertson DP:The metabolic response to injury and other related explorations in the field of protein metabolism:an autobiographical account. Scott Med, 27:158-171, 1982
59) Cuthbertson DP, et al:Post-shock metabolic response. 1942. Nutr Hosp, 16:175-182, 2001
60) Moore FD:Bodily changes in surgical convalescence. I. The normal sequence observations and interpretations. Ann Surg, 137:289-315, 1953
61) Moore FD:Edward Delos Churchill:1895-1972. Ann Surg, 177:507-508, 1973
62) 長谷部正治:古典的な生体反応の推移の分類. 「キーワードでわかる臨床栄養-栄養で治す!基礎から実践まで」(大熊利忠, 他/編), 羊土社, 2011
63) Browne JSL, et al:Protein metabolism in acute and chronic disease and the relation of protein metabolism to the excretion of gluco-corticoids. [Proceedings of the First Clinical ACTH Conference](More JR, ed), p108, The Blakiston Company, 1950
64) Selye H:Stress and the general adaptation syndrome. Br Med J, 4667:1383-1392, 1950
65) Gramlich L, et al:Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature. Nutrition, 20:843-848, 2004
66) Casaer MP, et al:Early versus late parenteral nutrition in critically ill adults. N Engl J Med, 365:506-517, 2011
67) Barker CF:Jonathan Rhoads, MD 1907-2002. Ann Surg, 235:740-744, 2002
68) Ravdin IS & Rhoads JE:Regional ileitis and fibroplastic appendicitis. Ann Surg, 106:394-406, 1937
69) Rhoads JE:Peritoneal lavage in the treatment of renal insufficiency. Am J Med Sci, 196:642-647, 1938
70) Thompson WD. et al:Use of lyophile plasma in correction of hypoproteinemia and prevention of wound disruption. Arch Surg, 36:509-518, 1938
71) Rhoads JE:The problem of nutrition in patients with gastric lesions requiring surgery. Western J Surg Gynec Obstet, 51:229-233, 1943
72) Rhoads JE, et al:The use of diuretics as an adjunct in parenteral hyperalimentation for surgical patients with prolonged disability of the gastrointestinal tract. Bull Soc Int Chir, 24:59-70, 1965
73) Taylor RW & Palagiri AV:Central venous catheterization. Crit Care Med, 35:1390-1396, 2007
74) Aubaniac R:Subclavian intravenous injection;advantages and technic. Press Med, 60:1456, 1952
75) Seldinger SI:Catheter replacement of the needle in percutaneous arteriography;a new technique. Acta Radiol, 39:368-376, 1953
76) Dudrick SJ, et al:Total intravenous feeding and growth in puppies. Fed Proc, 25:481, 1966
77) Dudrick SJ, et al:Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery, 64:134-142, 1968
78) Heyland DK, et al:Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA, 286:944-953, 2001
79) Dudrick SJ:The relationship of cardinal virtues and philosophy to research success. 第30回日本静脈経腸栄養学会学術集会・葛西森夫記念講演, 2015
80) Ehrlich R:Technique for microscopic count of microorganisms directly on membrane filters. J Bacteriol, 70:265-268, 1955
81) Richards OW & Krabek WB:Visibilizing microorganisms on membrane filter surface. J Bacteriol, 67:613, 1954
82) Wilmore DW & Dudrick SJ:An in-line filter for intravenous solutions. Arch Surg, 99:462-463, 1969
83) Accord3.0ホームページ http://www.accord3.com/docs/GM-Pesticides/team/Doug%20Wilmore%20cv.pdf
84) Banting FG:An Address on Diabetes and Insulin:Being The Nobel Lecture Delivered at Stockholm on September 15th, 1925. Can Med Assoc J, 16:221-232, 1926
85) 渡辺寛人:メイラード反応を阻害する成分の探策. 浦上財団研究報告書, 21:71-77, 2014
86) 小原正美, 他:アミノ酸の製造について. 有機合成化学協会誌通期合成化学, 20:676-687, 1962
87) Ruberg RL, et al:Hypophosphatemia with hypophosphaturia in hyperalimentation. Surg Forum, 22:87-88, 1971
88) Wilmore DW & Dudrick SJ:Growth and development of an infant receiving all nutrients exclusively by vein. JAMA, 203:860-864, 1968
89) Schnitker MA, et al:A clinical study of malnutrition in Japanese prisoners of war. Ann Intern Med, 35:69-96, 1951
90) Stanga Z, et al:Nutrition in clinical practice-the refeeding syndrome:illustrative cases and guidelines for prevention and treatment. Eur J Clin Nutr, 62:687-694, 2008
91) Crook MA, et al:The importance of the refeeding syndrome. Nutrition, 17:632-637, 2001
92) 中屋豊, 他:リフィーデイング症候群. 四国医学雑誌, 68:23-28, 2012
93) Doig GS, et al:Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults:a randomised, parallel-group, multicentre, single-blind controlled trial. Lancet Respir Med, 3:943-952, 2015
94) Awad S, et al:The history of 0.9% saline. Clinical Nutrition, 27:179-188, 2008
95) MacGillivray N:Sir William Brooke O'Shaughnessy(1808-1889), MD, FRS, LRCS Ed:Chemical pathologist, pharmacologist and pioneer in electric telegraphy. J Med Biogr, 25:1796-1833, 2017
96) Foex BA:How the cholera epidemic of 1831 resulted in a new technique for fluid resuscitation. Emerg Med J, 20:316-318, 2003
97) Cosnett JE:Dr. William Brooke O'Shaughnessy. The Old Limerick J, 29:13-16, 1992
98) MacGillivray N:Dr Thomas Latta:the father of intravenous infusion therapy. Jounal of Infection Prevention, 10(Suppl 1):s3-s6, 2009
99) McGrew RE:The first Russian cholera epidemic:themes and opportunities. Bulletin of the history of Medicine, 36:229, 1962
100) Bent Friis-Hansen:Salt and water therapy. History of Pediatrics 1850-1950. Nestle Nutrition Workshop Series, vol.22 Nestec Ltd., Vevery/Raven Press, Ltd., New York 1991
101) O'Shaughnessey WB:Proposal of a new method of treating the blue epidemic cholera by the injection of highly-oxygenated salts into the venous system. Lancet, 1:366-371, 1831
102) Masson AH:Latta--pioneer in saline infusion. Brit J Anesth, 43:681-686, 1971
103) Ferrie J:The first use of intravenous saline for the treatment of disease. Int J Epidemiol, 43:387-390, 2013
104) Latta T:"Malignant cholera." Documents communicated by the Central Board of Health, London, relative to the treatment of cholera by the copious injection of aqueous and saline fluids into the veins." Lancet, 2:274-277, 1832
105) Latta T:Saline venous injection in case of malignant cholera, performed while in the vapour-bath.(Letter)., Lancet, 2:208-209, 1932
106) Lewins R:Injection of saline solutions in extraordinary quantities into the veins of malignant cholera. Lancet, 2:243-244, 1832
107) Jennings CE:The intra-venous injection of fluid for several haemorrhage. The Lancet, 120:436-437, 1882
108) Pye-Smith RJ:Sheffield Public Hospital and Dispensary:five cases of intravenous injection of saline fluid for haemorrhage and collapse. Lancet, 139:913-915, 1898
109) Thomas WT:Injection of saline solution in shock. Lancet, 152:1390-1391, 1898
110) Lazarus-Barlow WS:On the Initial Rate of Osmosis of Blood-Serum with reference to the Composition of "Physiological Saline Solution" in Mammals. J Physiol, 20:145-57, 1896
111) Hamburger HJ:A discourse on permeability in physiology and pathology. Lancet, 198:1039-1045, 1921
112) Yunos NM, et al:Bench-to-bedside review:Chloride in critical illness. Crit Care, 14:226-235, 2010
113) Odaira T:The influence of some neutral salt solution, intravenously administered, on the reserve alkali of the blood. Tohoku J Exp Med, 4:523-526, 1923
114) Shires GT & Holman J:Dilution acidosis. Ann Intern Med, 28:557-559, 1948
115) Matas R:The continued intravenous "drip":with remarks on the value of continued gastric drainage and irrigation by nasal intubation with a gastroduodenal tube(jutte)in surgical practice. Ann Surg, 79:643-661, 1924
116) McFarlane C & Lee A:A comparison of Plasmalyte 148 and 0.9% saline for intra-operative fluid replacement. Anesthesiology, 49:779-781, 1994
117) Scheingraber S, et al:Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology, 90:1265-1270, 1999
118) Waters JH, et al:Cause of metabolic acidosis in prolonged surgery. Crit Care Med, 27:2142-2146, 1999
119) Reid F, et al:(Ab)normal saline and physiological Hartmann's solution:a randomized double-blind crossover study. Clin Sci, 104:17-24, 2003
120) Williams EL. et al:The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg, 88:999-1003, 1999
121) Li H, et al:0.9% saline is neither normal nor physiological. J Zhejiang Univ Sci B, 17:181-187, 2016
122) Stewart PA:Modern quantitative acid-base chemistry. Can J Physiol Pharmacol, 61:1444-1461, 1983
123) Wilcox CS:Regulation of renal blood flow by plasma chloride. J Clin Invest, 71:726-735, 1983
124) Kotchen TA, et al:Effect of chloride on renin and blood pressure responses to sodium chloride. Ann Intern Med, 98:817-822, 1983
125) Wilkes NJ, et al:The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg, 93:811-816, 2001
126) Lobo DN, et al:Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection:a randomised controlled trial. Lancet, 359:1812-1818, 2002
127) Brandstrup B, et al:Effects of intravenous fluid restriction on postoperative complications:Comparison of two perioperative fluid regimens. Ann Surg, 238, 641-648, 2003
128) Wilmore DW & Kehlet H:Management of patients in fast track surgery. BMJ, 322:473-476, 2001
129) Cotton BA, et al:The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock, 26, 115-121, 2006
130) Rhee P, et al:Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med, 28, 74-78, 2000
131) Horton JW, et al:Hypertonic saline dextran after burn injury decreases inflammatory cytokine responses to subsequent pneumonia-related sepsis. Am J Physiol Heart Circ Physiol, 290:H1642-1650, 2006
132) Healey MA, et al:Lactated ringer's is superior to normal saline in a model of massive hemorrhage and resuscitation. J Trauma, 45:894-899, 1998
133) Wakim KG:"Normal" 0.9 per cent salt solution is neither "normal" nor physiological. JAMA, 214:1710, 1970
134) Churton T:A case of the scirrhus of pylorus, with excessive vomiting;repeated intravenous injections of saline solution;remarks. Lancet, 620-621, 1888
135) Reddi BA:Why is saline so acidic(and does it really matter?). Int J Med Sci, 10:747-750, 2013
136) Santi M, et al:The great fluid debate:saline or so-called "balanced" salt solutions? Italian J Pediatrics, 41:47-51, 2015
137) Myburgh JA & Mythen MG:Resuscitation fluids. N Engl J Med, 369:1243-1251, 2013
138) Miller DJ:Sydney Ringer;physiological saline, calcium and the contraction of the heart. J Physiol, 555:585-587, 2004
139) Sydney R:A further Contribution regarding the influence of the different Constituents of the Blood on the Contraction of the Heart. J Physiol, 4:29-42, 1883
140) Reddy S, et al:Crystalloid fluid therapy. Crit Care, 20:59-67, 2016
141) Thongprayoon C, et al:Chloride alterations in hospitalized patients:Prevalence and outcome significance. PLoS One, 12:e0174430, 2017
142) Guidet B, et al:A balanced view of balanced solutions. Crit Care, 325, 2010. Published online 2010 Oct 21. doi:10.1186/cc9230
143) Rehm M & Finsterer U:Treating intraoperative hyperchloremic acidosis with sodium bicarbonate or tris-hydroxymethyl aminomethane:a randomized prospective study. Anesth Analg, 96:1201-1208, 2003
144) Boldt J, et al:Are lactated Ringer's solution and normal saline solution equal with regard to coagulation? Anesth Analg, 94:378-384, 2002
145) Boldt J, et al:The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients. Intensive Care Med, 35:462-470, 2009
146) Boldt J, et al:A new plasma-adapted hydroxyethylstarch preparation:in vitro coagulation studies using thrombelastography and whole blood aggregometry. Anesth Analg, 104:425-430, 2007
147) Waters JH, et al:Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair:an outcome study. Anesth Analg, 93:817-822, 2001
148) Boldt J, et al:Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. Anesth Analg, 109:1752-1762, 2009
149) Boldt J, et al:Volume replacement with a balanced hydroxyethyl starch(HES)preparation in cardiac surgery patients. J Cardiothorac Vasc Anesth, 24:399-407, 2010
150) Perel P, et al:Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev, 28:CD000567. doi:10.1002/14651858.CD000567.Pub6, 2013
151) Bunn F & Trivedi D:Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev, 13:CD001319, 2012
152) Cochrane Injuries Group Albumin Reviewers:Human albumin administration in critically ill patients:systematic review of randomised controlled trials. BMJ, 317:235-240, 1998
153) Finfer S, et al:SAFE study Investigators:A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med, 350:2247-2256, 2004
154) SAFE study Investigators:Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med, 357:874-884, 2007
155) Cooper DJ, et al:Albumin resuscitation for traumatic brain injury:is intracranial hypertension the cause of increased mortality? J Neurotrauma, 30:512-518, 2013
156) Finfer S, et al:Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med, 37:86-96, 2011
157) Finfer S, et al:Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units:analysis of data from the saline versus albumin fluid evaluation(SAFE)study. BMJ 2006;333:1044
158) Brunkhorst FM, et al:Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med, 358:125-139, 2008
159) Finfer S, et al:Resuscitation fluid use in critically ill adults:an international cross-sectional study in 391 intensive care units. Crit Care, 14:R185, 2010. doi:10.1186/cc9293
160) Perner A, et al:Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med, 367:124-134, 2012
161) Myburgh JA, et al:Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med, 367:1901-1911, 2012
162) Shaw AD, et al:Major complications, mortality, and resource utilization after open abdominal surgery:0.9% saline compared to Plasma-Lyte. Ann Surg, 255:821-829, 2012
164) Traverso LW, et al. Fluid resuscitation after an otherwise fatal hemorrhage:I. Crystalloid solutions. J Trauma, 26:168-175, 1986
165) Todd SR, et al:Lactated Ringer's is superior to normal saline in the resuscitation of uncontrolled hemorrhagic shock. J Trauma, 62:636-639, 2007
166) Kiraly LN, et al:Resuscitation with normal saline(NS)vs. lactated ringers(LR)modulates hypercoagulability and leads to increased blood loss in an uncontrolled hemorrhagic shock swine model. J Trauma, 61:57-64, 2006
167) Phillips CR, et al:Resuscitation of haemorrhagic shock with normal saline vs. lactated Ringer's:effects on oxygenation, extravascular lung water and haemodynamics. Crit Care 2009;13(2):R30. Published online 2009 Mar 4. doi:10.1186/cc7736
168) Noritomi DT, et al:Impact of Plasma-Lyte pH 7.4 on acid-base status and hemodynamics in a model of controlled hemorrhagic shock. Clinics(Sao Paulo), 66:1969-1974, 2011
169) Kellum JA, et al:Etiology of metabolic acidosis during saline resuscitation in endotoxemia. Shock, 9:364-368, 1998
170) Kellum JA, et al:Hyperchloremic acidosis increases circulating inflammatory molecules in experimental sepsis. Chest, 130:962-967, 2006
171) Lobo DN, et al:Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine(Gelofusine)and 6% hydroxyethyl starch(Voluven)on blood volume and endocrine responses:a randomized, three-way crossover study in healthy volunteers. Crit Care Med, 38:464-470, 2010
172) Aguilar-Nascimento JE, et al:Changes in body composition, hematologic parameters, and serum biochemistry after rapid intravenous infusion or oral intake of 2 liters of 0.9% saline solution in young healthy volunteers:randomized crossover study. World J Surg, 36:2776-2781, 2012
173) Chowdhury AH, et al:A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg, 256:18-24, 2012
174) Story DA, et al:Cognitive changes after saline or plasmalyte infusion in healthy volunteers:a multiple blinded, randomized, cross-over trial. Anesthesiology, 119:569-575, 2013
175) Chowdhury AH, et al:A randomized, controlled, double-blind crossover study on the effects of 1-L infusions of 6% hydroxyethyl starch suspended in 0.9% saline(voluven)and a balanced solution(Plasma Volume Redibag)on blood volume, renal blood flow velocity, and renal cortical tissue perfusion in healthy volunteers. Ann Surg, 259:881-887, 2014
176) Bihari S,. et al:Bolus intravenous 0.9% saline, but not 4% albumin or 5% glucose, causes interstitial pulmonary edema in healthy subjects. J Appl Physiol(1985), 119:783-792, 2015
177) Van Regenmortel N & Jorens PG:Effect of isotonic vs hypotonic maintenance fluid therapy on urine output, fluid balance, and electrolyte homeostasis:a crossover study in fasting adult volunteers. Reply from the authors. Br J Anaesth, 119:1065-1067, 2017
178) Krajewski ML, et al:Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation. Br J Surg, 102:24-36, 2015
179) Raiman M, et al:Comparison of hydroxyethyl starch colloids with crystalloids for surgical patients:A systematic review and meta-analysis. Eur J Anaesthesiol, 33:42-48, 2016
180) Potura E, et al:An acetate-buffered balanced crystalloid versus 0.9% saline in patients with end-stage renal disease undergoing cadaveric renal transplantation:a prospective randomized controlled trial. Anesth Analg, 120:123-129, 2015
181) Weinberg L, et al:Effects of intraoperative and early postoperative normal saline or Plasma-Lyte 148(R) on hyperkalaemia in deceased donor renal transplantation:a double-blind randomized trial. Br J Anaesth, 119:606-615, 2017
182) Kancir AS, et al:The effect of 6% hydroxyethyl starch 130/0.4 on renal function, arterial blood pressure, and vasoactive hormones during radical prostatectomy:a randomized controlled trial. Anesth Analg, 120:608-618, 2015
183) Pfortmueller CA, et al:Normal saline versus a balanced crystalloid for goal-directed perioperative fluid therapy in major abdominal surgery:a double-blind randomised controlled study. Br J Anaesth, 120:274-283, 2018
184) Rochwerg B, et al:Fluids in Sepsis and Septic Shock Group. Fluid resuscitation in sepsis:a systematic review and network metaanalysis. Ann Intern Med, 161:347-355, 2014
185) Moretti EW, et al:Intraoperative colloid administration reduces postoperative nausea and vomiting and improves postoperative outcomes compared with crystalloid administration. Anesth Analg, 96:611-617, 2003
186) Raghunathan K, et al:Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med, 42:1585-1591, 2014
187) Zhou FH, et al:Normal saline for intravenous fluid therapy in critically ill patients. Chin J Traumatol, 21:11-15, 2018
188) Semler MW, et al:Balanced Crystalloids versus Saline in Critically Ill Adults. New Engl J Med, 378:829-839, 2018
189) Self WH, et al:Balanced Crystalloids versus Saline in Noncritically Ill Adults. New Engl J Med, 378:819-828, 2018
191) Correa TD, et al:Balanced crystalloids for septic shock resuscitation. Res Bras Ter Intensiva, 28:463-471, 2016
192) Rochwerg B, et al:Fluids in Sepsis and Septic Shock Group. Fluid resuscitation in sepsis:a systematic review and network meta-analysis. Ann Intern Med, 161:347-355, 2014
193) Rochberg B, et al:Fluid type and the use of renal replacement therapy in sepsis:a systematic review and network meta-analysis. Intensive Care Med, 41:1561-1571, 2015
194) Young P, et al:SPLIT Investigators;ANZICS CTG. Effect of a buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit:The SPLIT Randomized Clinical Trial. JAMA, 314:1701-1710, 2015
195) Shaw AD, et al:Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome. Critical Care, 334-343, 2015
196) Basse L, et al:A clinical pathway to accelerate recovery after colonic resection. Ann Surg, 232:51-57, 2000
197) 宮田剛:ESSENSEとはなにか. 外科と代謝・栄養, 47:147-154, 2013
198) Kehlet H & Wilmore DW:Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg, 248:189-198, 2008
199) Fearon KC, et al:Enhanced recovery after surgery:a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr, 24:466-477, 2005
200) 寺島秀夫:周術期の栄養管理(2)-ERASプロトコール:実践に役立つ基礎と臨床の最新知見. 「キーワードでわかる臨床栄養 改訂版」(大熊利忠, 他/編), pp231-244, 羊土社, 2011
201) Tsuji H, et al:Attenuation of adrenocortical response to upper abdominal surgery with epidural blockade. Br J Surg, 70:122-124, 1983
202) Tsuji H, et al:Effects of epidural administration of local anaesthetics or morphine on postoperative nitrogen loss and catabolic hormones. Br J Surg, 74:421-425, 1987
203) Jonsson K, et al:Tissue oxygenation, anemia, and perfusion in relation to wound healing in surgical patients. Ann Surg, 214:605-613, 1991
204) Makaryus R, et al:Current concepts of fluid management in enhanced recovery pathways. Br J Anaesth, 120:376-383, 2018
205) Fonseca BK, et al:Enteral vs intravenous rehydration therapy for children with gastroenteritis:a meta-analysis of randomized controlled trials. Arch Pediatr Adolesc Med, 158:483-90, 2004
206) American Society of Anesthesiologists Committee:Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration:application to healthy patients undergoing elective procedures:an updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology, 114:495-511, 2011
207) Weimann A, et al:ESPEN guideline:Clinical nutrition in surgery. Clin Nutr, 36:623-650, 2017
208) Awad S, et al:A meta-analysis of randomised controlled trials on preoperative oral carbohydrate treatment in elective surgery. Clin Nutr, 32:34-44, 2013
209) Lobo DN, et al:Gastric emptying of three liquid oral preoperative metabolic preconditioning regimens measured by magnetic resonance imaging in healthy adult volunteers:a randomised double-blind, crossover study. Clin Nutr, 28:636-641, 2009
210) Shiraishi T, et al:Gastric Fluid Volume Change After Oral Rehydration Solution Intake in Morbidly Obese and Normal Controls:A Magnetic Resonance Imaging-Based Analysis. Anesth Analg, 124:1174-1178, 2017
211) Thiele RH, et al:American Society for Enhanced Recovery(ASER)and Perioperative Quality Initiative(POQI)joint consensus statement on perioperative fluid management within an enhanced recovery pathway for colorectal surgery. Perioper Med (Lond). 2016 Sep 17;5:24. doi:10.1186/s13741-016-0049-9.eCollection 2016
212) Srinivasa S, et al:Randomized clinical trial of goal-directed fluid therapy within an enhanced recovery protocol for elective colectomy. Br J Surg, 100:66-74, 2013
213) Nygren J, et al:Preoperative oral carbohydrate administration reduces postoperative insulin resistance. Clin Nutr, 17:65-71, 1998
214) Svanfeldt M, et al:Randomized clinical trial of the effect of preoperative oral carbohydrate treatment on postoperative whole-body protein and glucose kinetics. Br J Surg, 94:1342-1350, 2007
215) Smith MD, et al:Preoperative carbohydrate treatment for enhancing recovery after elective surgery. Cochrane Database Syst. 2014 Aug 14;(8):CD009161. doi::10. 1002/14651858
216) Hausel J, et al:Randomized clinical trial of the effects of oral preoperative carbohydrates on postoperative nausea and vomiting after laparoscopic cholecystectomy. Br J Surg, 92:415-421, 2005
217) Bellamy MC:Wet, dry or something else? Br J Anaesth, 97:755-757, 2006
218) Wind J, et al:Perioperative strategy in colonic surgery;LAparoscopy and/or FAst track multimodal management versus standard care(LAFA trial). BMC Surg. 2006 Nov 29;6:16. doi:10.1186/1471-2482-6-16
219) Bundgaard-Nielsen M, et al:'Liberal' vs. 'restrictive' perioperative fluid therapy--a critical assessment of the evidence. Acta Anaesthesiol Scand, 53:843-851, 2009.
220) Thacker JK, et al. Perioperative Fluid Utilization Variability and Association With Outcomes:Considerations for Enhanced Recovery Efforts in Sample US Surgical Populations. Ann Surg, 263:502-510, 2016
221) Shin CH, et al:Effects of Intraoperative Fluid Management on Postoperative Outcomes:A Hospital Registry Study. Ann Surg, 267:1084-1092, 2018
222) Gustafsson UO, et al:Adherence to the enhanced recovery after surgery protocol and outcomes after colorectal cancer surgery. Arch Surg, 146:571-577, 2011
223) Meng L & Heerdt PM:Perioperative goal-directed haemodynamic therapy based on flow parameters:a concept in evolution. Br J Anaesth, 117(suppl 3):iii3-iii17, 2016
224) Pearse RM, et al:Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery:a randomized clinical trial and systematic review. JAMA, 311:2181-2190, 2014
225) Salmasi V, et al:Relationship between Intraoperative Hypotension, Defined by Either Reduction from Baseline or Absolute Thresholds, and Acute Kidney and Myocardial Injury after Noncardiac Surgery:A Retrospective Cohort Analysis. Anesthesiology, 126:47-65, 2017
226) Benes J, et al:Intraoperative fluid optimization using stroke volume variation in high risk surgical patients:results of prospective randomized study. Crit Care, 14:R118, 2010
227) Myles P. et al.:Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery. N Engl J Med. 2018 Jun 14;378(24):2263-2274. doi:10.1056/NEJMoa1801601. Epub 2018
228) Varadhan KK & Lobo DN:A meta-analysis of randomised controlled trials of intravenous fluid therapy in major elective open abdominal surgery:getting the balance right. Proc Nutr Soc, 69:488-498, 2010
229) Thiele RH, et al:Standardization of care:impact of an enhanced recovery protocol on length of stay, complications, and direct costs after colorectal surgery. J Am Coll Surg, 220:430-443, 2015
230) Miller TE, et al:Fluid management and goal-directed therapy as an adjunct to Enhanced Recovery After Surgery(ERAS). Can J Anaesth, 62:158-168, 2015
231) Prien T, et al:Effect of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery. J Clin Anesth, 2:317-323, 1990
232) Mizota T, et al:Intraoperative oliguria predicts acute kidney injury after major abdominal surgery. Br J Anaesth, 119:1127-1134, 2017
233) Mazer-Amirshahi M & Fox ER:Saline Shortages-Many Causes, No Simple Solution. N Engl J Med, 378:1472-1474, 2018
234) Patino AM, et al:Facing the Shortage of IV Fluids-A Hospital-Based Oral Rehydration Strategy. N Engl J Med, 378:1475-1477, 2018
235) Munos MK, et al:The effect of oral rehydration solution and recommended home fluids on diarrhoea mortality. Int J Epidemiol, 1:i75-i87, 2010
236) Raman M, et al:Parenteral Nutrition and Lipids. Nutrients. 2017 Apr 14;9(4). pii:E388. doi:10.3390/nu9040388
237) Carpentier YA & Dupont IE:Advances in intravenous lipid emulsions. World J.Surg, 24:1493-1497, 2000
238) Anez-Bustillos L, et al:Intravenous Fat Emulsion Formulations for the Adult and Pediatric Patient:Understanding the Differences. Nutr Clin Pract, 31:596-609, 2016
239) Hallberg DH, et al:Fat emulsions for complete intravenous nutrition. Postgrad Med J, 43:307-316, 1967
240) Barr LH, et al:Essential fatty acid deficiency during total parenteral nutrition. Ann Surg:193:304-311, 1981
241) Holman RT:The ratio of trienoic:tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J Nutr, 70:405-410, 1960
242) Meng HC:A fat emulsion for intravenous nutrition in rabbits. J Lab Clin Med, 37:222-228, 1951
243) 木村信良, 他:経静脈的脂質補給に関する研究. 日本輸血学会雑誌, 16:17-16, 1969
244) 日笠頼則:脂肪乳剤の静脈内投与の研究. 日外会誌, 52:298, 1951
245) 谷村弘:国産脂肪乳剤Intralipos(TM)の臨床応用. Arch Jap Chir, 48:720-727, 1979
246) Meng HC:Use of fat emulsion in parenteral nutrition. Annals of Pharmacotherapy, 6:321-330, 1972
247) Schuberth O & Wretlind A:Intravenous infusion of fat emulsions, phosphatides and emulsifying agents. Acta Chir Scand Suppl, 278:1-12, 1961
248) 寺島秀夫:世界とわが国における脂肪乳剤の開発状況と今後の展望. 外科と代謝・栄養, 51:55-62, 2017
249) Fell GL, et al:Intravenous Lipid Emulsions in Parenteral Nutrition. Adv Nutr, 6:600-610, 2015
250) Vanek VW, et al:A.S.P.E.N. position paper:Clinical role for alternative intravenous fat emulsions. Nutr Clin Pract, 27:150-192, 2012
251) Biesboer AN & Stoehr NA:A product review of alternative oil-based intravenous fat emulsion. Nutr Clin Pract, 31:610-618, 2016
252) 入山圭二:脂質代謝. 「キーワードでわかる臨床栄養 改訂版」(大熊利忠, 他/編), pp96-102, 羊土社, 2011
253) Tashiro T, et al:n-3 versus n-6 polyunsaturated fatty acids in critical illness. Nutrition, 14:551-553, 1998
254) Calder PC, et al:Fatty acids and lymphocyte functions. Br J Nutr, 87:S31-48, 2002
255) Furukawa K, et al:Influences of soybean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients. Nutrition, 18:235-240, 2002
256) Qi K, et al:Omega-3 triglycerides modify blood clearance and tissue targeting pathways of lipid emulsions. Biochemistry, 41:3119-3127, 2002
257) Kumpf VJ:Parenteral nutrition-associated liver disease in adult and pediatric patients. Nutr Clin Pract, 21:279-290, 2006
258) Ulrich H, et al:Parenteral use of medium-chain triglycerides:a reappraisal. Nutrition, 12:231-238, 1996
259) Mok KT, et al:Structured medium-chain and long-chain triglyceride emulsions are superior to physical mixtures in sparing body protein in the burned rat. Metabolism, 33:910-915, 1984
260) Sala-Vila A, et al:Olive oil in parenteral nutrition. Curr Opin Clin Metab Care, 10:165-174, 2007
261) Deshpande GC, et al:Parenteral lipid emulsions based on olive oil compared with soybean oil in preterm(<28 weeks' gestation)neonates:a randomised controlled trial. J Pedatr Gastroenterol Nutr, 49:619-625, 2009
262) Gawecka A, et al:Immunologic properties differ in preterm infants fed olive oil vs soy-based lipid emulsions during parenteral nutrition. JPEN J Parenter Enteral Nutr, 32:448-453, 2008
263) de Meijer VE, et al:Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr, 50:212-218, 2010
264) Gura KM, et al:Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr, 24:839-847, 2005
265) Teitelbaum DH, et al:Proceedings From FDA/A.S.P.E.N. Public Workshop:Clinical Trial Design for Intravenous Fat Emulsion Products, October 29, 2013. JPEN, 39:768-786, 2015
266) 武藤充, 他:研究と臨床経験からみるバランス脂肪乳剤SMOFlipid(R) 20%の有用性. 外科と代謝・栄養, 51:91-102, 2017
267) Mechanisms of action of(n-3)fatty acids. J Nutr. 2012 Mar;142(3):592S-599S. doi:10.3945/jn.111.155259. Epub 2012
268) 入山圭二:脂肪乳剤の血管内代謝のしくみ Intravascular metabolism of lipid emulsions. 外科と代謝・栄養, 43:89-94, 2009
269) Carpentier YA, et al:Intravascular metabolism of lipid emaulsions containingω-3 fatty acids. Clinical Nutrition Suppl, 2:3-5, 2007
270) Brouwer CB. et al:Different clearance of intravenously administered olive oil and soybean-oil emulsions:role of hepatic lipase. Am J Clin Nutr, 57:533-539, 1993
271) Haumont D, et al, Plasma lipid and plasma lipoprotein concentrations in low birth weight infants given parenteral nutrition with twenty or ten percent lipid emulsion. J Pediatr, 115:78-93, 1989
272) Iriyama K. et al:Elimination rate of fat emulsion particles from plasma in Japanese subjects as determined by a triglyceride clamp technique. Nutrition, 12:79-82, 1996
273) Iriyama K. et al:Constant infusion rates of lipid emulsions to stabilize plasma triglyceride concentrations:medium-chain triglyceride/long-chain triglyceride emulsions(MCT/LCT)versus LCT. Surg Today Jpn J Surg, 28:289-292, 1998
274) 天江新太郎:短腸症候群とω-3系脂肪乳剤. 外科と代謝・栄養 49 :5-15, 2015
275) 木村信良:外科領域の栄養. 日本臨床外科医学会会誌, 50(増刊):33-40, 1989
276) Dr. Robert Elman:J Natl Med Assoc, 49:128, 1957
277) Hospital Record:Barnes Hospital ST. Louis Missouri, 11, 1957
278) Elman R & Weiner DO:Intravenous alimentation with special reference to protein(amino acid)metabolism. JAMA, 112:796-802, 1939
279) Elman R:Parenteral replacement of protein with the amino-acids of hydrolyzed casein. Ann Surg, 112:594-602, 1940
280) Wilson GS:The Pasteurization of Milk. Br Med J, 1:261-262, 1943
281) Madden SC, et al:Ten amino acids essential for plasma protein production effective orally or intravenously. J Exp Med, 277-295, 1943
282) Madden SC & Clay WA:Protein metabolism and protein reserves during acute sterile inflammation:high protein intake compensates for increased catabolism. J Exp Med, 81:65-76, 1945
283) Howe EE, et al:Comparative tolerance to mixtures of natural and racemic amino acids on intravenous infusion in the dog. J Biol Chem, 162:395-401, 1946
284) 岸恭一:タンパク質・アミノ酸必要量の過去, 現在, 未来. 日本栄養・食糧学会中部支部会設立40周年記念講演会, 講演集より. 2008
285) 日本人の食事摂取基準2015年版, 厚生労働省 https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/syokuji_kijyun.html
286) Young VR & Borgonha S:Nitrogen and amino acid requirements:the Massachusetts Institute of Technology amino acid requirement pattern. The Journal of Nutrition, 130:1841S-1849S, 2000
287) Ajinomoto Group Worldwide. Medical Care and Amino Acids. Amino acids are indispensable in the medical field. https://www.ajinomoto.com/features/amino/how/medical/
288) 疋田茂樹, 他:アミノ酸製剤, 静脈・経腸栄養. 日本臨床, 59(増刊):159-163, 2001
289) 武藤輝一, 他:新組成アミノ酸混合液(TA3712)の一般消化器外科症例高カロリー輸液における検討. 診療と新薬, 23:1145-1193, 1986
290) 平井慶徳, 他:新組成アミノ酸製剤(TEO-10)を窒素源とする高カロリー輸液. 薬理と治療, 14:403-459, 1986
291) Rose WC, et al:The utilization of the nitrogen of ammonium salts, urea, and certain other compounds in the synthesis of nonessential amino acids in vivo. J Biol Chem, 181:307-316, 1949
292) Rose WC & Dekker EE:Urea as a source of nitrogen for the biosynthesis of amino acids. J boil Chem, 223:107-121, 1956
293) Giordano C:USE OF EXOGENOUS AND ENDOGENOUS UREA FOR PROTEIN SYNTHESIS IN NORMAL AND UREMIC SUBJECTS. J Lab Clin Med, 62:231-246, 1963
294) Giordano C, et al:Incorporation of urea 15N in amino acids of patients with chronic renal failure on low nitrogen diet. Am J Clin Nutr, 21:394-404, 1968
295) Natale G, et al:Carmelo Giordano(1930-2016):a giant in Nephrology. Giornale Italiano di Nefrologia:1-22, 2017
296) Giovannetti S & Maggiore Q:A LOW-NITROGEN DIET WITH PROTEINS OF HIGH BIOLOGICAL VALUE FOR SEVERE CHRONIC URAEMIA. Lancet, 1:1000-1003, 1964
297) 出浦照國, 他:3. 慢性腎不全の低たんぱく食. 昭和医学会雑誌, 59:120-127, 1999
298) 浅野誠一:腎不全とその対策, 腎, 腎機能とその臨床. 日本内科学会雑誌, 46:912-926, 1968
299) Wilmore DW & Dudrick SJ:Treatment of acute renal failure with intravenous essential L-amino acids. Arch Surg, 99:669-673, 1969
300) Dudrick SJ, et al:Renal failure in surgical patients. Treatment with intravenous essential amino acids and hypertonic glucose. Surgery, 68:185-186, 1970
301) 中田一洋:慢性腎不全患者に対する必須アミノ酸療法の検討. 日本腎臓学会誌, 20:29-46, 1978
302) 片岡美紀子, 他:腎不全用アミノ酸液(AMI-U-II)の研究-第1報 虚血性急性腎不全ウサギに対する効果. 日本腎臓学会誌, 20:1023-1036, 1978
303) Heird WC, et al:Hyperammonemia resulting from intravenous alimentation using a mixture of synthetic l-amino acids:a preliminary report. J Pediatr, 81:162-165, 1972
304) Rapp RP, et al:Hyperammonia encephalopathy in a patient receiving essential amino acid/dextrose parenteral nutrition. Clin Pharm, 1:276-280, 1982
305) Lamielle JJ, et al:Essential amino acid-induced adult hyperammonemic encephalopathy and hypophosphatemia. Crit Care Med, 18:451-452, 1990
306) Akpolat T:Hyperammonemic encephalopathy due to intravenous essential amino acid administration in a patient with renal insufficiency. Nephron, 63:239, 1993
307) Yoshimura NN:Intravenous essential amino acid therapy. Nephron, 67:131-132, 1994
308) Nakasaki H, et al:Complication of parenteral nutrition composed of essential amino acids and histidine in adults with renal failure. JPEN J Parenter Enteral Nutr, 17:86-90, 1993
309) Varcoe R, et al:Efficiency of utilization of urea nitrogen for albumin synthesis by chronically uraemic and normal man. Clin Sci Mol Med, 48:379-390, 1975
310) 片岡美紀子, 他:腎不全用総合アミノ酸製剤MRX-IIIの慢性腎不全ラットに対する効果. 日本腎臓学会誌, 35:1131-1138, 1993
311) Kapila S, et al:Arginine deficiency-induced hyperammonemia in a home total parenteral nutrition-dependent patient:a case report. JPEN J Parenter Enteral Nutr, 25:286-288, 2001
313) Kornerup LS, et al:Update on the Therapeutic Management of Hepatic Encephalopathy. Curr Gastroenterol Rep, 20:21-26, 2018
314) Swaminathan M, et al:Hepatic encephalopathy:current challenges and future prospects. Hepat Med, 10:1-11, 2018
315) Holecek M:Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives. Metab Brain Dis, 29:9-17, 2014
316) Freund H, et al:Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy. Ann Surg, 196:209-220, 1982
317) Hasselgren PO, et al:Festschrift for Josef E. Fischer, MD. Am J Surg, 183:325-392, 2002
318) Fischer JE & Baldessarini RJ:False neurotransmitters and hepatic failure. Lancet, 2:75-80, 1971
319) Aguirre A, et al:Plasma amino acids in dogs with two experimental forms of liver damage. J Surg Res, 16:339-345, 1974
320) Fischer JE, et al:The role of plasma amino acids in hepatic encephalopathy. Surgery, 78:276-290, 1975
321) Smith AR, et al:Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann Surg, 187:343-350, 1978
322) Rosen HM, et al:Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology, 72:483-487, 1977
323) Rossi-Fanelli F, et al:Induction of coma in normal dogs by the infusion of aromatic amino acids and its prevention by the addition of branched-chain amino acids. Gastroenterology, 83:664-671, 1982
324) Fischer JE, et al:The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery, 80:77-91, 1976